Yuanyuan Yang

3.8k citations
145 papers · 3.0k indexed · h-index 29
Topics
Kidney Stones and Urolithiasis Treatments (16 papers)Advanced biosensing and bioanalysis techniques (14 papers)Ubiquitin and proteasome pathways (8 papers)

In The Last Decade

Yuanyuan Yang

136 papers receiving 2.9k citations

Peers

Yuanyuan Yang
Comparison fields: 5 of 129
  • Molecular Biology 1.8k
  • Oncology 612
  • Cancer Research 535
  • Biomedical Engineering 344
  • Genetics 316
Replace Xu He with:
Xu He China
Gopeshwar Narayan India
Xiaozhong Wang China
Xiaoqing Wang China
Elizabeth A. Leibold United States
Diane W. Cox Canada
Lisheng Wang China
Xiaoying Yin China
Ya Zhang China
Yong An China
Yuanyuan Yang relative to Xu He China Xu He's profile →
Citations per field
00.5×1.5×
Xu He · 1×
Citations per year

Countries citing papers authored by Yuanyuan Yang

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Yang more than expected).

Fields of papers citing papers by Yuanyuan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Yang. The network helps show where Yuanyuan Yang may publish in the future.

Co-authorship network of co-authors of Yuanyuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Yang. A scholar is included among the top collaborators of Yuanyuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Yang. Yuanyuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 0
3 20
4 52
5 2
6 15
7 9
8 3
9 3
10 1
11 8
12 10
13 21
14 30
15 5
16
[Direct interactions between human mesenchymal stem cells and ovarian cancer cells].
2
17 20
18 22
19 116
20 8

About Yuanyuan Yang

Yuanyuan Yang is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 145 papers that have together received 3.0k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (16 papers), Advanced biosensing and bioanalysis techniques (14 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Cancer Research (535 citations), Genetics (316 citations) and Molecular Biology (1.8k citations). Yuanyuan Yang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ralf Hass, Catharina Melzer, Anna Otte, Juliane von der Ohe, Zhichao Zhang, Xuhong Qian, Qin Xu, Shaorong Gao, Heike Bähre and Shaogang Wang. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026